From Mithra Deal Announcement 1 October on Reuters
This gives more indication of the size of the E4 Estelle opportunity for MYX. It is no wonder Mithra is grabbing 9.6% of MYX at current prices
Mithra Signs Landmark Contract For Estelle® With Mayne PharmaOct 1 (Reuters) - MITHRA PHARMACEUTICALS SA ::MITHRA SIGNS LANDMARK CONTRACT FOR ESTELLE® IN THE UNITED STATES WITH MAYNE PHARMA.
MITHRA ELIGIBLE FOR LICENSE FEES OF AT LEAST USD 295 MILLION.MITHRA TO BE AWARDED 9.6% EQUITY STAKE ACROSS TWO TRANCHES IN MAYNE PHARMA.
POTENTIAL GROSS REVENUES IN MITHRA'S WORST-CASE SCENARIO AT A MINIMUM OF EUR 4,5 BILLION, WHICH REPRESENTS MORE THAN TWICE SIZE OF EUROPEAN DEAL.
CDMO CROSS FERTILIZATION OPPORTUNITIES FOR BOTH COMPANIES.PARTIES WILL WORK TOGETHER ON REGULATORY SUBMISSION PLANNED BY END 2019 WITH PROJECTED COMMERCIAL LAUNCH OF ESTELLE® IN H1 2021.
From Mithra Deal Announcement 1 October on ReutersThis gives...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.34 |
Change
0.080(1.88%) |
Mkt cap ! $369.2M | |||
| Open | High | Low | Value | Volume |
| $4.27 | $4.35 | $4.25 | $408.4K | 94.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1900 | $4.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.35 | 579 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |